Today in Science, researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2 antibody fragments from llamas, which could be fashioned into inhalable therapeutics with the potential to prevent...
University of Pittsburgh
Category
ACTIV-2 Clinical Trial Comes to University of Pittsburgh School of Medicine: Investigators Test LY-CoV555 & Potentially Ab8
The University of Pittsburgh School of Medicine (Pitt) represents one of 25 initiated trial site organizations investigating novel therapies targeting the earlier stages of COVID-19 in a bid to start focusing on early treatment to reduce disease progression. Pitt has...
University of Pittsburgh Secures $1m NIH Grant for Collaboration with Tiba Biotech Developing RNA-based COVID-19 Vaccine
Researchers at the University of Pittsburgh (Pitt) now pursue three COVID-19 vaccines, including 1) the PittCoVac announced by TrialSite News on April 3; 2) the investigational vaccine out of Pitt’s Center for Vaccine Research in collaboration with Austrian biotech...
University of Pittsburgh Researcher on the Verge of SARS-CoV-2 Findings Murdered
A researcher with University of Pittsburgh in pursuit of a COVID-19 therapy on the verge of “making very significant findings” related to SARS-CoV-2 was found dead as the result of an apparent murder-suicide. Dr. Bing Liu was found dead at home with gunshot wounds to...
University of Pittsburgh’s Experimental COVID-19 Vaccine Called ‘PittCoVacc’ Works on Mice
University of Pittsburgh School of Medicine researcher scientists have a potential vaccine targeting SARS-CoV-2. Pre-clinical research on mice reveal that the fingerprint-sized patch produces antibodies specific to the novel coronavirus at quantities thought to be...
Multinational Group including University of Pittsburgh Secure $5m for COVID-19 Vaccine Development
An international academic-industry partnership raised nearly $5 million from the international, intergovernmental organization Coalition for Epidemic Preparedness Innovations (CEPI) for the develop a vaccine for COVID-19. University of Pittsburgh Regional...
University of Pittsburgh Center for Vaccine Research Receives $5m as Part of Collaborative Targeting COVID-19
The University of Pittsburgh’s Center for Vaccine Research, part of an international team studying COVID-19, received nearly $5 million to combat the novel coronavirus. The funds further tighten an integrated research network, in Paris, Vienna, France, and Pittsburgh,...
University of Pittsburgh Joins Disruptive AI-based Federated Learning Network to Advance Clinical Research
The University of Pittsburgh has partnered with AI and Federated Learning technologies startup to help augment medical research and enable scientific discoveries. In first establishing a pilot agreement, the University of Pittsburgh will leverage its own high-quality...
CSL Behring & University City Science Center Accelerate Research for New Biotherapies with Grant Awards
University of Pittsburgh and University of Delaware researchers received funding for research covering innovative therapies targeting pulmonary fibrosis (FB) to Gene delivery to or editing Hematopoietic (blood) Stem and Progenitor Cells (HSPCs). Two clinical...
Renowned Cancer Surgeon Norman Wolmark Joins UPMC to Direct Clinical Trials
Prominent surgeon and cancer investigator Norman Wolmark has left Allegheny Health Network to lead the University of Pittsburgh and the UPMC Hillman Cancer Center. Dr. Wolmark will now become professor of surgery at the University of Pittsburgh School of Medicine as...
UPMC Study Evidences Open Heart Surgery Superior to Stents for More than One Blocked Artery
University of Pittsburgh Medical Center (UPMC)’s Suresh R. Mulukutla, MD led a study to determine whether coronary artery bypass grafting (CABG) surgery would outperform percutaneous coronary intervention (PCI). The answer: Yes. The UPMC-led team disclosed that the...
University of Pittsburgh Public Health Uncover Swiss Army Knife for HIV
David Lopez reports from Instinct Magazine a group of University of Pittsburgh Graduate School of Public Health the development of an all-in-one immunotherapy that will “kick” HIV out of hiding in the immune system and “kill” it. The researchers refer to it as a...